Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOLINE-2
2024-515038-34-00Phase 4Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of donepezil in Alzheimer's disease (AD) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Change in MMSE score from baseline to 6 months between arms. Planned start Oct 2024; status: authorised.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2024-515038-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515038-34-00.